About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,255 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,255 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3061-3080 of 4,255 trials

CompletedObservational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or DepressionThis study is aimed to evaluate the bipolar disorder symptoms in patients presented with schizophrenia, schizoaffective disorder or recurrent depression.NCT01028196·Chita and 2 others CompletedTC-5619 as Augmentation Therapy to Improve Cognition in Outpatients With Cognitive Dysfunction in SchizophreniaSchizophrenia affects approximately 1% of the population worldwide, and in about 80% of cases, it is a lifelong, disabling illness.NCT01003379·National City, California and 15 others

Related Searches

Data from ClinicalTrials.govTerms

CompletedTrial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar DisorderThis is a two-part trial.NCT03872596·Long Beach, California

CompletedAssessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With SchizophreniaSchizophrenia is a serious mental health condition that affects individuals' thinking, perception, emotional responses, and behavior.NCT07141966·Istanbul

TerminatedStudy in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible DoseThis pilot trial in Finland is designed to evaluate in a randomized fashion change of agitation in acute schizophrenic patients (Schizophrenia or Schizoaffective psychosis or…NCT00660595·Harjavalta and 3 others

WithdrawnStudy Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of SchizophreniaThis study will evaluate the clinical safety and tolerability of vabicaserin in Japanese subjects that have a sudden worsening of their symptoms of schizophrenia.NCT00768612

CompletedIntegrated Care Including Assertive Community Treatment in Early PsychosisImprovement of clinical long-term outcome through the implementation of early detection and intervention within a specialized network of integrated care (ACT and hometreatment)…NCT02037581·Hamburg

CompletedEffectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for PsychosisThis study will evaluate the effectiveness of intensive computerized cognitive training in preventing the onset of psychotic disorder and improving adaptive functioning in…NCT00655239·San Francisco, California

Completede-Learning & Development of an Evidence-based Psychoeducational Programme for First Episode PsychosisTreatment delay in psychosis usually lead to slower recovery, an increase in associated comorbidity and greater deterioration in social and family life of patients.NCT01783457·Barcelona, Barcelona and 5 others

CompletedTolerability and Pharmacokinetics of Iloperidone in Adolescent PatientsTolerability, undertstanding of the action of the drug in the body, and understanding the effect of the drug in adolescent patients needing treatment with an antipsychotic…NCT01495169·Costa Mesa, California and 9 others

RecruitingPersonalized Metacognitive Training for Psychosis: A Randomized Controlled TrialThis study aims to compare the efficacy of classical Metacognitive Training (MCT) and personalized Metacognitive Training (P-MCT) for individuals with psychosis.NCT07146802·Strasbourg

CompletedThe Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health CenterThis study will establish a bi-weekly Consta Club. Participants will begin taking Risperdal Consta after being recommended by their treating physician.NCT00845572·San Antonio, Texas

CompletedPhysical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia PatientsAssessment of physical activity levels, physical fitness and quality of life of bipolar and schizophrenia patients is necessary to verify the effectiveness of treatments and care…NCT07140042·Istanbul, Istanbul

CompletedMetabolic Profile and Anthropometric Changes in Schizophrenia"No clinical differences will be found between the three antipsychotics under study - olanzapine, risperidone and haloperidol - on the patients' metabolic profile and weight. "NCT00534183·Ranchi

CompletedOnline TP (Training Program) on SC (Social Cognition) for SchizophreniaRandomized controlled trial. Sixty-five participants (83% with schizophrenia or bipolar disorder) were recruited from community mental health teams.NCT05866328·San Cristóbal de La Laguna, Santa CRUZ DE Tenerife

UnknownAssertive Community Treatment in CopenhagenThe aim of the study is to evaluate the effect of assertive community treatment in Copenhagen in two regions compared with two regions where this treatment was not implemented.NCT00225602·Copenhagen, Copenhagen

CompletedStudy to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver DiseaseThe purpose of this study is to evaluate the tolerability and safety of paliperidone ER (extended-release) in doses between 3 milligrams per day and 12 milligrams per day in the…NCT00535145·Cerritos, California and 20 others

TerminatedSodium Nitroprusside in Early Course SchizophreniaPeripheral inflammation and microvascular dysfunction are central to the pathophysiology of schizophrenia (SZ).NCT04986072·Boston, Massachusetts

Not yet recruitingA Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017This is a phase 1，randomized, double-blind, placebo-controlled, MAD study to evaluate the safety, tolerability and pharmacokinetics of oral LPM526000133 Fumarate Capsules…NCT06980207·Shanghai

CompletedClinical and Biological Characteristics of Psychotic DepressionThe primary objective of this study is to investigate the relationships among findings in structural and functional neuroimaging, cognitive testing and HPA…NCT00576095·Stanford, California

PreviousPage 154 of 213Next